Overall responsibility for optimizing the design and performance of supply chains within the Oncology Therapy Area including our IMFINZI® and IMJUDO® brands. Serving as Global Operations Lead and single point of contact for the brand's supply chains in our commercial business units. Leading Global Supply Team to ensure market demands are analyzed and incorporated into the product strategy roadmap.Defining the end to end global supply chain, including strategy & investment decisions for the Antibody Drug Conjugate (ADC) portfolio. Manage supply from clinical development (Phase II/III) through end of product life cycle.Driving transformation projects to deliver supply resilience and enhanced organization capabilities (cost to serve, sustainability, risk management).

Product Champion aligning technical operations with regulatory and commercial strategies to ensure successful launches and uninterrupted global supply. Global CMC (Chemistry, Manufacturing, & Controls) team lead with end-to-end program oversight for product specifications, critical raw materials, drug substance manufacture, drug product manufacture, and device assembly, label, and package.Drove life cycle management of biologics within the Respiratory & Immunology, Oncology, and COVID-19 product portfolio from development phase through to launch, post-approval regulatory filings, and commercial manufacture.

• National Professionals Chair Emeritus, NSBE, 2023-2024• National Professionals Chair, NSBE, 2022-2023• National Professionals Chair-Elect, NSBE, 2021-2022• Director Emeritus, Healthcare Innovation Special Interest Group (HISIG), 2021-2022• Director, Healthcare Innovation Special Interest Group (HISIG), 2019-2021• Treasurer, Healthcare Innovation Special Interest Group (HISIG), 2017-2019• Professionals Treasurer, Region 2 (Mid-Atlantic), 2015-2016• Professionals Membership Chair, Region 2 (Mid-Atlantic), 2013-2014• President Emeritus, Washington DC Professionals Chapter, 2013-2014• President, Washington DC Professionals Chapter, 2011-2013 • Treasurer, Washington DC Professionals Chapter, 2010-2011 • Finance Chair, Washington DC Professionals Chapter, 2010-2011 • Delegate, Washington DC Professionals Chapter, 2010-2011, 2012-2013 • Regional Leadership Chair, Region 4 (Midwest), 2008-2009 • National Leadership Conference Planning Committee, 2008-2009 • Finance Chair, University of Michigan-Ann Arbor Chapter, 2005-2007 • Conference Planning Chair, University of Michigan-Ann Arbor Chapter, 2004-2005 Technology innovation requires the advancement of engineering. And today, more than ever, advancement of the engineering profession depends on the work of the National Society of Black Engineers (NSBE). With more than 30,0000 members globally, NSBE is governed by an executive board of both collegiate students and engineering professionals, and is operated by its World Headquarters staff in Alexandria, VA

Technical Manager, Biopharm & Steriles Technical Team, with accountability as Site Product Owner supporting external supply. Accountable for BENLYSTA drug substance transfer, qualification and ongoing lifecycle management.

Provide technical oversight and product lifecycle management for biopharm products at two GMP facilities including cross functional matrix leadership for risk management, change management, and knowledge management. Manage bulk drug substance team and upstream working group for BENLYSTA, facilitate major investigations, drive continued process verification, process validation and process performance qualification (PPQ), lead new product introductions, deliver artificial intelligence and machine learning (AI / ML) productivity improvement projects, and tech transfer of next generation products from lab to commercial scale for Manufacturing Sciences team.

Re-Nuble is a startup that has developed a patent pending process to transform vegetative/food waste into non-toxic, liquid hydroponic nutrients that help boost hydroponic yields at a fraction of the cost of chemically based alternatives.

SolGreen® Solutions is a startup clean tech company that designs and manufactures innovative solar products like the SolGreen® Evodia Solar Table. Plug In. Chill Out. Grid Out. This premium charging station enhances mobile user convenience, comfort, and experience.

• Technology Transfer: Interfaced with internal and external research, development and manufacturing partners to ensure process compatibility of human vaccines and immunotherapy candidates (e.g. Tuberculosis, Ebola, Flu, Zika).• Product & Process Development: Provided engineering expertise to produce medical countermeasure drug products and scale up platforms for pre-clinical and process characterization activities. Supported Cell Culture / Fermentation (Upstream), Purification (Downstream), Formulation, and Analytical Development project teams.

• Led and executed fermentation, extraction, recovery, and process modeling work plans as part of global multi-disciplinary team network.• Advanced early and late stage development projects and improved manufacturing processes that transformed microbial fermentations (yeast, algae, fungi) into a variety of consumer products with human health, animal health, and bioenergy applications.DSM is now a division of dsm-firmenich

Process Research and Development - Exploratory and Pioneering Technologies Group Martek Biosciences is now a division of DSM

Analytical Reaction Engineering Lab - Supercritical Gasification

Process engineering and maintenance intern for clinical and commercial biologics campaigns at Abbvie Bioresearch Center.

Bionanotechnology for Drug Delivery

Manufacturing intern for active pharmaceutical ingredient (API ) product recovery and purification campaigns

Nuclear and Radiochemistry